🟢 Clover Health is trading 21% up today after second-quarter earnings beat expectations

Clover Health is trading 21% up at $5.00 after its August 5, 2026, second-quarter report beat expectations.

• Revenue was $743.2 million, with GAAP earnings of $0.05 per share.
• The company raised full-year revenue, adjusted EBITDA, GAAP net income, gross profit, and membership guidance.
• Trading is active during the August 6, 2026, market session. The earnings-driven reaction follows an August 5 close of $4.14, while broader indexes are mixed and do not clearly explain the move.